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Dr F. Meadors (Little Rock, Ark). I have a question for you,
Dr Miller, and the panel. If you have a patient who is going to re-
quire graft replacement in the ascending aorta, how big does the
true transverse aortic arch have to be before the panelists would
convert from a hemiarch replacement to either a conventional
open arch, total replacement, or a hybrid?
Dr Miller. Is it a bicuspid aortic valve or a trileaflet aortic valve?
I think that makes a very important difference.
Dr Meadors. I think it is certainly pertinent to pose the scenario
of the patient with bicuspid valve because that denominator is go-
ing up with the baby boomers coming into middle age. Therefore I
would take the easy way out and ask for answers to both scenarios.
Dr Miller. Therefore the question is how big does the arch have
to be to make you go beyond a simple open distal or hemiarch to
a total arch in both trileaflet and bicuspid aortic valve disease.
My response would be to parrot back what I learned at this meeting
over 20 years ago from E. Stanley Crawford and that is to use the
patient’s own meter stick or yardstick when the aneurysm or
what you are thinking about replacing exceeds the normal contig-
uous aorta by a ratio of 2. E. Stanley used this rule of thumb for pa-
tients with Marfan syndrome way back when, and I have found it to
work pretty well. But he admitted, and I will admit also, that we do
not have one shred of scientific evidence to back that up. However,
this barometer of 23 works pretty well, remembering that the de-
nominator for a patient with a bicuspid aortic valve cannot be the
distal ascending aorta because it way too often tends to be dilated.
It has to be the distal arch for the denominator on a patient with a bi-d at Aortic Surgery Symposium 2010, New York, NY, Thursday, April 29,
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The Journal of Thoracic and Cardiovascular Surgcuspid valve, whereas the distal ascending or proximal arch might
be okay in a patient with a trileaflet valve. Therefore it does not take
much in my book, especially for young elective cases because it
does not add to the risk. For the patients with trileaflet valves, prob-
ably I would be a little less aggressive, but patients with bicuspid
valves tend to be younger, and I think we have to do a better job
up front to confer the most durable repair we can.
Dr Stewart. I would agree with you.With patients with bicuspid
valves, we tend to be a bit more aggressive and move to a total arch
when you exceed 2 to 1. You have to make the patient’s operation
individual as well, though, and in some of the older patients, you
can generally almost perform a total arch by using a method I think
you described, a peninsula operation in which you can just leave the
greater curve and take the whole arch essentially off and reconstruct
it with a very aggressive hemiarch. We do that more often than not
for patients with trileaflet valves.
Dr Bavaria. I think there is some science to the bicuspids.
I think a total arch operation with a bicuspid valve is almost never
necessary. It is backed up by the fact that if you look at data from
embryology and arch development from lots of basic scientists, the
whole bicuspid valve gene penetration is about at the proximal and
middle arch. It does not go much more distal than that. Therefore
I almost never do a full-blown aortic arch procedure.
Dr Miller. Wait a minute. Neural crest development starts at the
ligamentum and goes retrograde. You said proximal arch?
Dr Bavaria. No. There are data that suggest that bicuspid aortic
valve pathology ends at the mid arch, and the only exception to
that is when you start having coarctation issues. Therefore I do
not do very many full arch procedures in patients with bicuspid
valves because I do not think they really need that. To answer
your question about tricuspid atherosclerotic disease, if you start
having 5- or 5½-cm aortas, you should probably go down and do
kind of a first-stage elephant trunk type of procedure to get rid of
the full arch in cases like that.
Dr Di Bartolomeo. Sometimes, in patients with bicuspid aortic
valves, the aortic arch is small or hypoplastic. In these cases I am
very aggressive and replace the ascending and the full arch. In cases
of tricuspid aortic valve, the extension of the arch replacement de-
pends on the size of the aneurysm, the age, the etiology, and so on.
Dr Miller. Do I interpret your remarks correctly by saying you
are more aggressive in the younger patients with bicuspid valves
than you are in the older patients with trileaflet valves?
Dr Di Bartolomeo. Yes.ery c December 2010
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valve gene, thinks they have a transforming growth factor b2 mu-
tation. You operate on them, even at 4 cm, because they are prone to
dissection and rupture. With regard to the elephant trunk procedure,
if the descending thoracic aorta is big or it is going to dilate because
of dissection, I would use the standard elephant trunk procedure.
Otherwise, I will resect most of the lesser curvature and the lateral
wall of the aorta, and it seems this is very stable.
Dr Spielvogel. I tend to agreewithDr Safi. If the descending aorta
is really normal and you just have sort of a dilatation at the proximal
aorta into the arch, I think you can resect most of the underside of the
aortic arch with an extended hemiarch and remove the pathology
without resorting to a full arch. My only question is this: What was
the descending aorta like?Was there aneurysmal disease there where
you did not expect to be coming back? In that case, I think youwould
like to put in an elephant trunk and do a full arch replacement.
Dr Ogino. I think total arch replacement is not necessary in most
patients with bicuspid aortic valves because the dilated part is lim-
ited to the proximal arch. Therefore I think hemiarch replacement is
a good operation for patients with bicuspid aortic valves.
Dr Bekkers. I think it is nice to make an anastomosis on a rather
normal-sized aorta, and therefore I try to resect or remove as much
as needed until the aorta returns to normal. Whether that is some
kind of an extended hemiarch or needs to be a full arch with an
anastomosis either distal to the subclavian artery or at the level of
the subclavian artery can be decided during the operation.
Dr Di Luozzo. Basically if a patient has a bicuspid aortic valve
and a normal-sized descending thoracic aorta, data from our insti-
tution indicate that just a hemiarch replacement is good enough.
The need for a distal aortic reoperation is very, very low. I think
in our series it might be 1 of more than 200 patients who required
a distal aortic reoperation. Therefore based on our data, I think just
a hemiarch is all that is needed.
Dr Stulak. Having presented a congenital topic, and this admit-
tedly not being an area of expertise for me, what I have seen at
Mayo Clinic with Dr Sundt is basically the same as what Gabe
has said. If there is a normal distal aorta, then he can do most of
his resections with a hemiarch.
Dr Wheatley. I agree, a hemiarchwould be our approach aswell.
Dr N. Kouchoukos (St Louis, Mo). I have a question for
Dr Bavaria. Some of the 3-dimensional reconstructions you
showed of these distal arch aneurysms suggest that they could be
easily dealt with from a left thoracotomy, resecting only the very
distal part of the aortic arch. You might have to reimplant the sub-
clavian artery, but you would not have to do anything to the left
carotid or innominate arteries. Why not use that procedure? You
indicated that there was a 20% stroke rate associated with open
operation, and I would take strong issue with that. Some of
Dr Stanley Crawford’s data from the 1990s, when he was putting
clamps on the aorta, indicated a 20% stroke rate. With circulatory
arrest, however, you do not need to place any clamps on the aortic
arch, and the prevalence of stroke is quite low. I would suggest that
hybrid procedures are unnecessary for these cases in which the
aneurysm is in the very distal arch.
Dr Bavaria. I think if you can get into a zone 2 landing with
a regular thoracic endovascular aortic repair (TEVAR), then you
would do that. Therefore we would never operate on any of those
cases if we can get into zone 2 with a stent. To do a thoracotomyThe Journal of Thoracic and Caron a patient who has a proximal descending aortic aneurysm with
an adequate zone 2 landing is something I would avoid: I would
stent in every case. Therefore the question is this: What about
something that precludes landing in zone 2, which then means
you have to come in and maybe do a left chest case? These patients
all have big atherosclerotic aneurysms, and most of those patients
have very high atherosclerotic burdens and are really bad smokers.
We believe that a fourth interspace, high reverse, hemiarch distal
arch procedure from the left chest or from an anterior clamshell
is just not appropriate in these cases. We have learned from the vol-
ume reduction data in thoracic surgery that a sternotomy compared
with a thoracotomy in patients with chronic obstructive pulmonary
disease is so much better tolerated. Therefore a proximal median
sternotomy-based solution, in our opinion, is a better option here.
Dr Kouchoukos. But you really have not shown that the mortal-
ity rate or the stroke, renal failure, or paraplegia rates are any better.
Dr Bavaria. I do not even think you need to show that they are
any better. Even if they are the same, it is still probably preferable
for the patients to go in from the front compared with the back. We
are still early in this business. I just showed you the meta-analysis. I
think the world literature only shows about 180 cases. We will have
to see how it goes, but noninferiority is really all you need here.
Dr Miller. Let me ask a few zingers here. Allen, in the first ses-
sion you were telling us about your neat 3f valve in a De Paulis
graft. You are too young probably to know that Christian Cabrol
in Paris did all of his composite valve grafts for 30-plus years,
even going back to the Starr–Edwards ball valve days, sewing
the valve way up, leaving a cuff, and then sewing the cuff of the
graft to the annulus. But that is what led him to have to create,
out of misery, the Cabrol II mustache coronary revascularization
when the coronaries would not reach because it was too high.
Have you seen that with your new technique?
Dr Stewart. Interestingly, Dr Coselli just reminded me that
Dr Cabrol did that. We have not had a problem. I mobilize the but-
ton from the bottom up and do not spend too much time mobilizing
the sides. I just have not had that problem.
Dr Miller. Yet.
Dr Stewart. Well, we have done a good number now, and we
have not had any difficulties. That skirt at the bottom is not very
long.We usually go about 3 rings up with our sutures, and therefore
really it is not a long skirt underneath the valve.
Dr Miller. Maybe the examples we saw in the movies were
before you cut them down.
Roberto, you talk about paraplegia of 7.5%with the long frozen
trunk with the E-vita, and I do not know whether that is chronic A,
acute A, or B dissection, but you are covering a lot of intercostals,
and I am worried that the paraplegia rate might be excessively high.
I am also worried about the chronic dissections, A or B, in which
you are stuffing an E-vita into a very tiny frozen true lumen. Tell
us how you avoid trouble there.
Dr Di Bartolomeo. We had 1 episode of paraplegia in a 52-
year-old patient with chronic type A dissection. Two weeks after
the operation, we performed magnetic resonance imaging, and
we found that the patient had an angioma at T5; we do not know
whether the cause was this angioma. Another episode of paraplegia
occurred in a patient undergoing intervention for a very bad athero-
sclerotic aorta with 3 large aneurysms involving the arch, the prox-
imal descending aorta, and more distally the infrarenal aorta. Thediovascular Surgery c Volume 140, Number 6S S87
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cases. Embolism? Insufficient spinal circulation?
Dr Miller. Therefore your advice to us would be to study the
intercostals carefully and only go as far you need to distally?Would
that be the safest course of action?
Dr Di Bartolomeo. Generally we use only the angio–computed
tomographic scan and sometimes an aortogram, but it is difficult
preoperatively to stabilize the patient.
Dr Miller. The open E-vita, which we do not have in this coun-
try, does it come in different lengths for the stent graft part? Do you
have a choice of length for the stent?
Dr Di Bartolomeo. The length is 15 or 16 cm, but it is also pos-
sible to get a shorter stent graft of 10 cm.
Dr Miller. A custom-ordered shorter stent graft.
Dr R. Griepp (New York, NY). I don’t like to speak up, but with
the degree of ignorance about spinal cord perfusion, I think I have
to say something. I can guarantee you that I can take a patient and
ligate T3, which is usually the first intercostal artery coming off the
aorta, to T7 a hundred times and never get a spinal cord injury, and I
challenge those of you who do descending thoracic aortic surgery
to remember the last time you had a paraplegia if your distal anas-
tomosis ended above T8 or T10. Nonetheless, this phenomenon of
paraplegia in frozen elephant trunks has been reported by a lot of
practitioners. I am not sure of the reason. One thing I am confident
about is that it is not taking those intercostals out of the circulation.
It might well be embolization down one: if you embolize an inter-
costal artery and obstruct an end artery into the cord, you will have
a localized infarct and possibly paraplegia or paraparesis. But I do
not think depriving the body of the upper few intercostal arteries in
itself will cause a neurologic injury. I would be curious to hear
whether anyone else has an explanation for why you can resect
the aorta from the left subclavian artery to the mid and lower
descending thoracic aorta almost every time without a neurologic
injury, but when you do this with a frozen elephant trunk procedure
or TEVAR, you see neurologic injury in a significant percentage.
Dr Miller. The skeptics would say because your technique
involves progressive ischemic preconditioning of the cord as you
sequentially work down, and you do not have that advantage
with sudden TEVAR coverage. Any other theories of why there
is a difference from the panelists?
Dr Ogino. Regarding spinal cord injury after open stent graft-
ing, I try to demonstrate the Adamkiewicz artery by means of
computed tomographic scanning or magnetic resonance imaging
preoperatively, particularly in operations on the descending and
thoracoabdominal aorta. In most the Adamkiewicz artery originates
between T8 and L1, but in a few patients it originates at the level of
T6 or T7. Therefore I think we have to be more careful about the
level of the Adamkiewicz artery in endovascular settings. Too
long an elephant trunk or too long a stent graft can be very danger-
ous in terms of spinal cord injury.
Dr Bavaria. We have done a lot of stents with hybrids and stan-
dard endovascular deployment up to about T7. We have had no
paraplegia except in one subcategory, which is with intramural
hematoma cases, which might be because you are throwing
a kind of junk into the spinal arteries.
Dr Miller. Does that include the traumatic tears?
Dr Bavaria. We have never had a spinal injury from a traumatic
tear. We have had strokes but not spinal injury.S88 The Journal of Thoracic and Cardiovascular SurgDr Miller. The paper presented in Banff by your younger
faculty colleague?
Dr Bavaria. We had a stroke, and we had some intramural
hematoma cases.
Dr Miller. I recall it was a traumatic tear.
Dr T. Hanke (Luebeck, Germany). I have a question for
Dr Bekkers from The Netherlands. You conclude that there is
a high number of reoperations in the Ross patient population. Do
you think, as does one of your Dutch colleagues in a comment
in the Annals, that almost 100% will undergo reoperation? Do
you agree with me that with special surgical maneuvers like the
subcoronary technique or the reinforced full root, we can decrease
this dramatic reoperation rate into more of a normal range?
Dr Bekkers. One thing for sure is that we are going to see more
patients coming out having dilated aortas. Whether it will be all
those patients remains to be seen, but there will be more. Of course,
I am aware that a lot of colleagues advocate reinforcement either
only at the site of the proximal anastomosis or as a full jacket
around the whole aorta. The latter I can imagine will prevent the
root from dilatation. If one reinforces only the proximal part of it,
it is conceptually difficult for me to understand why that should
prevent the whole aorta from dilating and not only the annulus.
Dr Miller. Dr Bekkers, were all of your Ross procedures done as
a full root?
Dr Bekkers. No, they were not, but this report was only for
the full roots. We had some dilatation, but not as much as seen
with either a cylindrical inclusion or other techniques. This was a
report only on 155 roots.
Dr Miller. I think that was Thorsten’s point: if you do them the
way the operation was designed to be done, as a subcoronary scal-
loped operation way back when, as Hans Sievers and you just
reported (the article will be out next month), you would not see
these dilatation problems.
Dr Bekkers. That might be. The other thing is that nowadays we
reserve these operations especially for younger growing patients,
and then it is hard to use any reinforcement with material that
will not grow. We are hoping to see how the aorta and components
can grow as the patient grows. Our experience is that whether it is
a young patient or an old patient, they all receive these dilatations,
and we think it will be hard to prevent that, especially in the youn-
ger group.
Dr Miller. Tell us about the Luebeck series, which is phenom-
enal. I think you were a coauthor?
Dr Hanke. Yes. With the subcoronary technique and the rein-
forced root, we were able to show that freedom from reoperation,
at least after 10 years, was 94% and not 88% as with the nonsup-
ported root. Therefore with the special surgical maneuvers, with
a full root or the subcoronary technique, it seems, at least in the
midterm, that there are better results. We do not know much about
15 years, and your data are great for all these 15-year survivors, so
we will have to wait. However, we think with the original Donald
Ross technique, we might be able to get better results.
Dr J. Bachet (AbuDhabi, United Arab Emirates)My comments
are addressed to Dr Spielvogel. You have shown us a very elegant
technique, and I will not be critical of this, although in many
instances I think that the conventional arch replacement with an
island reimplantation of the vessels is easier. However, I think
that your outstanding results could be improved. I was very happyery c December 2010
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could perfuse the brain continuously without interrupting cerebral
perfusion because you are cannulating the subclavian artery.
Why do you not perfuse the brain continuously? Second, I think
that you could improve your results by getting rid of deep hypother-
mia.Why do you not do the procedure with moderate hypothermia?
Do the distal anastomosis. Then when you have anastomosed the
main prosthesis to the distal aorta, reimplant your trifurcated pros-
thesis into this main prosthesis, reperfuse the patient, rewarm the
patient, and during the rewarming, do the proximal repair. You
will save time on bypass and degrees in temperature, and your
results will most probably be a little better.
Dr Spielvogel. Thank you for your suggestions. In many pa-
tients, particularly patients with degenerative aneurysms and dis-
sections, you can occlude the brachiocephalic vessels. However,
in those patients with extensive atherosclerotic burden, there are
times we have had to resect, particularly in the innominate artery,
almost up to the bifurcation to clear it of atherosclerotic disease.
In those patients you cannot occlude the innominate artery and
begin selective cerebral perfusion. Therefore I think in the athero-
sclerotic subset you have to be particularly careful about doing any
instrumentation or clamping of those vessels, and that is one of the
reasons why we have stayed away from the approach you suggest.
However, there are patients in whom you can certainly do it.
In terms of the issue with hypothermia, if you look at the history
of those who presented today, several have created very complex
methods for perfusing the head and the lower body in an attempt
to avoid using hypothermia. What we have found is that to preserve
end organs in the lower body, it is very simple: just cool to a suffi-
cient degree, and then, with the protection of hypothermia, you can
go about your repair in an unhurried fashion and not worry that you
are going to have renal failure, paraplegia, or some kind of ischemic
event to the liver. As you saw, our reoperation rate for bleeding was
not particularly high for this kind of operation. Although you can
do it as you describe, we have stayed away from elaborate perfusion
schemes and kept it as simple as possible. I always believe that if
someone is going to adopt your procedure, it will be because
they can understand it and perform it on an occasional basis without
the requirement that they be in a major center that does a lot of sim-
ilar cases. I guess that is part of the reason why we have not added
those additional maneuvers. But thank you for your comment.
Dr Bachet. If you allow me, Craig, I have another question for
the panelists. Why do you use so much Teflon felt in chronic
patients? I have seen videos in which you could make the patient
a Stetson with the felt that was used.
Dr Miller. I have not used Teflon felt in16 years, and that is why
I have so many hats.
Dr Stewart. I do not use any felt.
Dr Bavaria. I use no felt.
Dr Miller. No felt.
Dr Di Bartolomeo. I use it.
Dr Safi. Well, I use Teflon felt and pledgeted sutures, and I call
them the home team. I want to go home. And I do not use the French
glue or the cryo glue.
Dr Bachet. But in chronic patients we do not use the glue either.
We just use the patient’s aorta.
Dr Safi. In the chronic patient, the chronic dissection or medial
degenerative aneurysm, if you put in real stitches—2–0 or 3–0 poly-The Journal of Thoracic and Carpropylene sutures—sometimes there is a tear in the intima. I promise
you, I spend days and nights trying to stop bleeding from outside. If
you put felt in prophylactically, you go home, and there is no
problem with it, and there is no incidence of infection. The biggest
patch is the graft: Why are we worried about the Teflon patch?
Dr Miller. Hazim, try some 4–0 or 5–0 sutures. David, we know
what you are going to say: felt, lots of it.
Dr Ogino. For 70% or 80% of my cases, I use felt.We havemore
than3,000 cases at theNationalCardiovascularCenter.The frequency
of pseudoaneurysm formation is quite low. I think the Teflon felt
contributes to the prevention of pseudoaneurysm formation.
Dr Bekkers. I like 4–0 Prolene sutures without felt.
Dr Di Luozzo. I use felt.
Dr Stulak. Dr Sundt uses felt.
Dr Wheatley. No shortage of felt in Arizona.
Dr Griepp. I would like to see publication on the rate of false
aneurysm formation from those who do not use felt. We have pub-
lished our incidence; it is in the literature. With felt, the rate is
something like 1 false aneurysm per 357 patient-years looking
back at all of our computed tomographic scans. Therefore if you
do not use felt, fine, but give us some idea of how well it works.
Dr Miller. While we have Dr. Spielvogel here, let’s talk about
your elephant trunk procedure: 7% stroke rate for the first stage,
and then up to a year, there was another 7% stroke rate, and you
said most of those occurred during the second-stage operation.
How can that be when it takes just a few seconds or a minute to
reach in and grab the trunk and clamp it? Why are the patients
exposed to such a high risk of stroke at the second stage?
Dr Spielvogel. That is a very good question. We had a number
of patients who had strokes not so much as the result of the proxi-
mal reconstruction but in whom their habitus affected their cerebral
perfusion. For example, we had a very obese patient, and the posi-
tioning in the right lateral decubitus position resulted in a very high
central venous pressure during the thoracotomy with an inadequate
arterial pressure, and therefore there was relative hypoperfusion of
the brain, causing cerebral injury. We now recognize that we have
to be very careful in maintaining adequate blood pressure in
patients in that position. Also, once you clamp proximally, the cen-
tral pressure can go very high, and patients who have undiagnosed
cerebral aneurysms can have an intracerebral bleed.
Dr Miller. Is that why you are on the pump, to keep them
decompressed?
Dr Spielvogel. That is the case, but we unfortunately had a few
patients in whom that happened.
Dr J. Appoo (Calgary, Alberta, Canada). I have one point and
a question for the panel. My point is about paraplegia with short
stent grafts and why that might occur even though you are not sac-
rificing intercostals below T7 or T8. It could be due to spinal cord
steal, which you do not see when you actually tie off the intercos-
tals. However, maybe if you put in a stent graft, you actually have
backward steal from the spinal cord.
I was interested in hearing that they use the E-vita graft for
chronic dissections. I wanted to ask the panel how they handle
the sort of patient we see a lot: the 70-year-old man who is 5 or
10 years out after a type A repair who has had a hemiarch done
but still has a dissection flap in the arch. The aorta has grown
over the last 5 to 10 years, and the distal arch is aneurysmal; the
proximal middescending thoracic aorta is aneurysmal, perhapsdiovascular Surgery c Volume 140, Number 6S S89
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estrations. How many people would re-enter, do a median sternot-
omy, and do some sort of hybrid approach with an E-vita type of
graft or something else, as opposed to trying to manage this patient
with circulatory arrest from the left chest to repair his distal arch and
thoracic aneurysm?
Dr Miller. My answer is simple. It depends on how pathologi-
cally damaged the arch is. If there is going to be very little to sew up
there, I would not want to be looking up through a left thoracotomy,
hoping to do something quick. I would stage it with a total arch and
a full surgical trunk, followed by whatever later.
Dr Stewart. I agree.
Dr Bavaria. I agree, for the most part, and that is the reason why
when we do these type A dissections to begin with, we should be
doing operations in which we do not leave a whole lot of arch
and distal false lumen, so that we do not have this situation. There
is one caveat: if you have a reasonable proximal landing zone of
some sort, which might or might not be the case, and you have
the celiac artery, superior mesenteric artery, and both renal arteries
coming off the true channel, I would stent those cases. Those cases
do really, really well.
Dr Di Bartolomeo. A chronic dissection?
Dr Miller. Chronic type A dissection with a previous ascending
hemiarch.
Dr Di Bartolomeo. This is a perfect indication for the frozen
elephant trunk procedure.
Dr Appoo. Do you find that there is still perfusion in the false
lumen when you do that?
Dr Di Bartolomeo. I do not perfuse the false lumen.
Dr Miller. Do you see it later?
Dr Appoo. Because of fenestrations. If the patient has a 7-cm
aneurysm, part is true lumen and part is false lumen, and the graft
sits in the true lumen. If you still perfuse the false lumen through
fenestrations below, is that a concern for you?
Dr Di Bartolomeo. I do not understand.
Dr Miller. You still have persistent flow in the large distal false
lumen below your elephant trunk.
Dr Di Bartolomeo. In most cases we have observed complete
thrombosis of the false lumen. In case of retrograde perfusion at
the false lumen, an additional stent can be placed 1 or 2 months
afterward.
Dr Miller. This is a major difference in philosophy and maybe
the laws of the country. In Italy it is legal to stent graft a chronic
dissection. Be careful in North America: you will go to jail. I do
not think it works, I do not think it is very effective, and it is futile
because of that exact point. You are going to have far too many
fenestrations, and even if the false lumen does thrombose, there
is going to be endotension in the false lumen. You have not con-
ferred protection from rupture.
Dr Safi. Well, I do exactly what you said: a classic elephant
trunk procedure and wait for 6 weeks and do the thoracoabdominal
procedure, and my associate, Dr Tony Estrera, is going to explain
our recent results.
Dr Spielvogel. Again, I think I would follow your tack with
a redo arch elephant trunk procedure, and then, depending on
how the distal aorta looks, an open completion or endograft. How-
ever, one thing we have forgotten is that if it is accessible in the left
chest, Dr Kouchoukos has operated on a number of patients likeS90 The Journal of Thoracic and Cardiovascular Surgthis with a thoracosternotomy or a clamshell incision. Doing it all
in one stage, you might be able to resect from your previous graft
down to your distal extent, and Dr Kouchoukos has had excellent
results. Therefore that is also an option if you think the patient
can tolerate that type of procedure.
Dr Miller. I am glad you brought up Nick’s thoracosternotomy,
which was just updated and published recently.
Dr Ogino. I prefer a 2-stage approach with total arch replace-
ment initially, with an elephant trunk procedure in the elderly.
The second procedure actually depends on the patient’s condition.
If the patient can tolerate a thoracotomy, I prefer an open repair, but
if that is not possible, I do a TEVAR, as Dr Bavaria said.
Dr Bekkers. I would preferably go through the left chest under
deep hypothermic circulatory arrest and do some kind of a hemiarch
from the other side.
Dr Stulak. Dr Sundt would do a total arch elephant trunk pro-
cedure, and then stage II would be through the left chest.
Dr Wheatley. I am going to side with our international col-
leagues: we would do a hybrid debranching and stenting, obviously
under institutional review board approval as part of a research study.
Dr Di Luozzo. I would do a 2-stage approach. I did not under-
stand Dr Appoo’s first point about the steal phenomenon with the
stent. Can you clarify that?
Dr Appoo. The question was this: Why were some of these
patients with short stent grafts having paraplegia when Dr Griepp
said you could ligate all the intercostals down to T10 and not get
spinal cord ischemia? Maybe when you put in a stent graft you
are covering the intercostals but the orifices are still open, so there
is actually retrograde flow. Instead of the vessels perfusing the spi-
nal cord, the intercostals are actually stealing blood from the spinal
cord. With time, those intercostals could thrombose, but in the
acute setting they might actually be patent.
Dr Bavaria. What you are saying is that there are small type II
endoleaks?
Dr Appoo. Yes, in theory.
Dr C. Young (London, United Kingdom). We heard 2 articles
today looking at long, thin, small grafts going up to the cerebral
vessels, and this worries me: I wonder what the rest of the panel
thinks about it. With the ones that we have done before, using
reverse transit grafts, we have had a lot of blockages, and we would
aim to go with individual grafts, probably 12 mm, up to the under-
side of the subclavian. The other aspect that Dr Bavaria did not
mention is that most of the patients we see for hybrid procedures
have had previous TEVARs, and the problem is that they are left
with endoleaks, type I endoleaks, into the arch. They are going
back in this sort of redo setting. You did not mention that, and I
wonder what your experience was.
Dr Miller. I think Joe has an extensive experience with that
problem: going back in the arch for a proximal 1A endoleak after
TEVAR.
Dr Bavaria. The second question is about the cases in which we
performed the hybrid procedure. We do a lot of secondary proce-
dures for type I endoleaks, which is pretty common. However,
for this particular series, we only had 1 patient who underwent
intervention elsewhere; it was a traumatic case. Therefore we
only had 1 of the 27 cases that was a proximal endoleak disaster.
The other 26 cases were actually classic hybrid procedures. And
we have had no—zero—zone 0 endoleaks, which we think isery c December 2010
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endoleaks in zone 0 if you put stents in overly large aortas. We do
not do that. I tried to point that out: when we do zone 0 landings, we
do not do them in 4-cm aortas.
Dr Miller. You made that quite clear. You said 3.5 cm, and if it
is bigger than that, you are going to replace it at zone 0.
Dr Bavaria. That is correct. We have had zero type I endoleaks
in our hybrid procedures. Your first question, about small grafts
into the cerebral vessels, I thought was very significant. I happen
to agree with you completely. It is a little bit worse to have a
single-branch 14-mm graft come off to the whole brain and arms.
I am wondering whether the 7% stroke rate in the second stage
of an elephant trunk procedure is related to some sort of issue
regarding low flow, or maybe there is also some compression of
the airway. Fear of low flow through small grafts is the reason
why the vascular surgeons who do debranching operations come
off with a single graft. I tend to not do that and come off with mul-
tiple grafts to the cerebral circulation.
Dr Miller. David, you gave us what long-term follow-up you
had, admitting that it was neither complete nor very long term,
but I think you were quite honest. We do not know, but you are
not aware of any problems yet?
Dr Spielvogel. No. Actually, I recently got a call from a referring
doctor who had a patient with a problem. The first hybrid procedure
that I did was in 1999 in an elderly woman in whom I moved the left
carotid and innominate arteries to the ascending aorta because of
occlusive disease and then stented the arch retrograde with the
old excluder. She is actually now more than 10 years out, and
both of those grafts are widely patent. This doctor had to put
another stent graft below the old one because she dilated her distal
aorta and had a type I endoleak. We are following these patients
very closely, and we have patients out over 10 years with grafts
that are widely patent. Clearly this is a concern of ours. I think
you should try and keep the limbs as short as possible. When you
measure them, and we do, the average limb length is quite short.
Again, we will continue to follow these patients, and we will see.The Journal of Thoracic and CarDr Miller. Maybe that multibranch graft, when you turn these
heavy people on their side for the second stage, might be where
you are having an issue. I have to correct myself (which is common
because I make a bunch of errors), but the Japanese study was not
the first randomized controlled study of cerebral protection in arch
surgery. Dr Griepp reminded me that Professor Bonser in Birming-
ham did a small one, and also Lars Svensson, when he was at the
Lahey Clinic, did one looking at S100. Again, small numbers,
but the Japanese, we commend you: that is what we need. That is
real evidence, but the numbers are so small that even had you
seen a difference, it might have been suspect. Is there hope that
this JSTAR2 study can be continued? Is there funding to get bigger
numbers?
Dr Ogino. That is a good question. Time is limited, and fund-
ing is also limited. Therefore we have discontinued the random-
ized controlled study. The power analysis regarding the JSTAR1
suggested that we should have 50 patients in each limb, but
as you know, we had fewer than 50% of this number: this is
a weakness.
Dr Miller. So your funding dried up and you cannot continue to
randomize?
Dr Ogino. It is quite difficult to continue it. At the moment, our
patient age has increased: the patients are 75 or 80 years old, and
their aortic pathology is also quite complex. This study is just for
isolated total arch replacement without any concomitant procedures
for low-risk patients having simple aortic pathology. In 2004, when
we planned this study, 50% of the patients had simple disease, but
in 6 years, the aortic pathology has become more complex. There-
fore it is quite difficult to continue the randomized controlled study
for patients having simple disease.
Dr Miller. And the surgeons do moderate or more deeply hypo-
thermic cerebral perfusion depending on how they feel about each
patient? Some will go very cold and some will stay warm depend-
ing on the patients at the various hospitals? Have the results of the
study changed their practice patterns? They probably do what they
did anyway.diovascular Surgery c Volume 140, Number 6S S91
